1 vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention —Reply
In Reply In response to the 1-year primary analysis of the STOPDAPT-2 trial, Dr Tan commented on the appropriateness of the noninferiority margin and the actual timing of aspirin discontinuation in the 1-month DAPT group.
Source: JAMA - Category: General Medicine Source Type: research
More News: Angioplasty | Aspirin | Coronary Angioplasty | General Medicine | Percutaneous Coronary Intervention